|
USCN Life
human ifna10 kit  Human Ifna10 Kit, supplied by USCN Life, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more https://www.bioz.com/product/IFNA10+ELISA+Kits/pmc04441321-150-5-20?v=USCN+Life Average 90 stars, based on 1 article reviews
human ifna10 kit - by Bioz Stars,
2026-06
90/100 stars
|
Buy from Supplier |
|
An ELISA kit for the detection of IFNA10 Human This uses Sandwich ELISA Double Antibody and has a sensitivity of 9 375ng ml
|
Buy from Supplier |
Image Search Results
Journal: Scientific Reports
Article Title: Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients
doi: 10.1038/srep10514
Figure Lengend Snippet: Genotype association study of the IFNA10 and IFNA4 variants in expanded CD cases versus controls.
Article Snippet: ELISAs were performed using the
Techniques:
Journal: Scientific Reports
Article Title: Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients
doi: 10.1038/srep10514
Figure Lengend Snippet: Association of IFNA4 variant with responses to medical treatment in CD Patients.
Article Snippet: ELISAs were performed using the
Techniques: Variant Assay
Journal: Scientific Reports
Article Title: Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients
doi: 10.1038/srep10514
Figure Lengend Snippet: Sequencing and functional analysis of the IFNA4 and IFNA10 variants. ( A ) Confirmation of the IFNA4 and IFNA10 heterozygous mutations in CD patients compared to healthy subjects (wild-type alleles) using Sanger sequencing. ( B ) The mutation site and amino acids alteration of the IFNA4 and IFNA10 variants. ( C-D ) Huh7 cells were transiently transfected with plasmids expressing IFNA4, IFNA10, or mutants and then infected with HCV; the replicon copies were calculated using real-time PCR and PLV as a control; The supernatants of the cell culture were analyzed using ELISA. ( E ) Real-time PCR analyzed the mRNA expressions of IFNA4, IFNA10, FOXP3, TGFβ, IL10, IL2, IL6 and IL17 in NCM460 cells after transfection of the siRNA targeting IFNA4 and IFNA10. The scramble siRNA sequences were used as a negative control. The results indicate the mean ± SD of three independent experiments (* P < 0.05).
Article Snippet: ELISAs were performed using the
Techniques: Sequencing, Functional Assay, Mutagenesis, Transfection, Expressing, Infection, Real-time Polymerase Chain Reaction, Control, Cell Culture, Enzyme-linked Immunosorbent Assay, Negative Control
Journal: Scientific Reports
Article Title: Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients
doi: 10.1038/srep10514
Figure Lengend Snippet: ELISA analysis of serum IFNA4 and IFNA10 levels. A Wilcoxon two-sample test was performed to evaluate the differences between 47 CD patients and 95 healthy controls. Comparison of the serum IFNA4 level between CD patients and healthy controls ( A ) and between wild-type and mutant alleles in CD patients and healthy controls ( B ) N indicates normal healthy control. Comparison of the serum IFNA10 level between CD patients and healthy controls ( C ) and between wild-type and mutant alleles in CD patients and healthy controls ( D ). ( E-F ) Comparison of serum IFNA4 and IFNA10 between IFN single-subtype and dual-subtype variants in CD patients, respectively (* P < 0.05).
Article Snippet: ELISAs were performed using the
Techniques: Enzyme-linked Immunosorbent Assay, Comparison, Mutagenesis, Control
Journal: Scientific Reports
Article Title: Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients
doi: 10.1038/srep10514
Figure Lengend Snippet: IFNA4 and IFNA10 control DSS-induced acute colitis. ( A-B ) Left panel showed the experimental protocol applied to induce mice acute colitis and the administration of IFNA subtypes; and right panel showed the mice body weight curve of DSS-induced acute colitis between the study groups. ( C ) The study mice were monitored for bleeding scores by a quantitative analysis for the presence of rectal blood. ( D-E ) Colon sections were fixed in formalin and stained with HE; the sections were analyzed for the inflammation score. ( F ) Real-time PCR analyzed the mRNA expressions of CCL2, CCL5, CD70, CXCL10 and TNFSF10 in colon tissues on DSS model. The data are given as the mean ± SD (n = 10, * P < 0.05).
Article Snippet: ELISAs were performed using the
Techniques: Control, Staining, Real-time Polymerase Chain Reaction
Journal: Scientific Reports
Article Title: Exome sequencing identifies novel compound heterozygous IFNA4 and IFNA10 mutations as a cause of impaired function in Crohn’s disease patients
doi: 10.1038/srep10514
Figure Lengend Snippet: IFNA4 and IFNA10 inhibit acute colitis through induction of Treg cells. ( A-B ) FACS analysis of isolated cells from mice DSS-induce acute colitis groups, upper panels indicate first gate of lower panels. (C-D) Quantification analysis of upper FACS results, as CD4 + CD25 + cells in CD3 + and Foxp3 + cells in CD4 + T cells in the colon tissues, 5 mice in each group and analyzed the samples in triplicate, bars represent the mean ± SD.
Article Snippet: ELISAs were performed using the
Techniques: Isolation